Stocktoria

ACCURAY INC ARAY

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2007-02-08 · LEI

ACCURAY INC financials (annual)

Revenue
$398.8M $383.4M $404.9M $418.8M $382.9M $396.3M $429.9M $447.6M $446.6M $458.5M 2016201720182019202020212022202320242025
Net income
-$25.5M -$29.6M -$23.9M -$16.4M $3.8M -$6.3M -$5.3M -$9.3M -$15.5M -$1.6M 2016201720182019202020212022202320242025
Free cash flow
$25.5M -$5.4M $12.1M -$34.0M -$5.0M $36.2M -$7.1M $2.9M -$15.5M -$1.4M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$458.5M$446.6M$447.6M$429.9M$396.3M$382.9M$418.8M$404.9M$383.4M$398.8M
Gross profit$147.0M$142.9M$154.0M$160.0M$159.5M$149.7M$162.7M$161.7M$141.3M$158.7M
R&D expense$47.9M$49.7M$57.1M$57.8M$52.7M$49.8M$56.5M$57.3M$49.9M$56.7M
Operating income$7.8M$504,000$2.4M$8.1M$22.2M$12.5M$583,000-$3.8M-$9.8M-$4.9M
Interest expense$13.0M$11.6M$10.6M$8.1M$16.9M$18.1M$15.1M$15.0M
Income tax$2.7M$3.7M$2.5M$3.3M$1.8M$1.9M$2.1M$878,000$1.0M$2.3M
Net income-$1.6M-$15.5M-$9.3M-$5.3M-$6.3M$3.8M-$16.4M-$23.9M-$29.6M-$25.5M
EPS (diluted)$-0.02$-0.16$-0.10$-0.06$-0.07$0.04$-0.19$-0.28
Operating cash flow$2.9M-$11.9M$15.5M-$2.4M$38.5M-$1.5M-$29.6M$18.3M-$380,000$33.5M
Free cash flow-$1.4M-$15.5M$2.9M-$7.1M$36.2M-$5.0M-$34.0M$12.1M-$5.4M$25.5M
Cash & equivalents$57.4M$68.6M$89.4M$88.7M$116.4M$107.6M$76.8M$83.1M$72.1M$119.8M
Inventory$141.0M$138.3M$145.2M$142.3M$125.9M$134.4M$120.8M$108.5M$105.1M$116.0M
Total assets$470.2M$468.6M$479.2M$472.8M$480.1M$490.9M$438.2M$378.7M$406.5M$469.0M
Total liabilities$389.1M$423.5M$425.6M$419.7M$411.3M$427.3M$388.3M$330.1M$359.9M$409.4M
Shareholders' equity$81.2M$45.1M$53.7M$53.2M$68.8M$63.6M$49.9M$48.6M$46.5M$59.7M

Growth · year-over-year · Revenue CAGR 1.6%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+2.7%-0.2%+4.1%+8.5%+3.5%-8.6%+3.4%+5.6%-3.9%+5.0%
Net income growth-264.9%
EPS growth-275.0%
Free cash flow growth-630.1%-119.7%-381.6%-121.2%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.